Genovis AB (publ.) Future Growth
Future criteria checks 2/6
Genovis AB (publ.) is forecast to grow earnings and revenue by 16.4% and 10.1% per annum respectively. EPS is expected to grow by 21.3% per annum. Return on equity is forecast to be 14.8% in 3 years.
Key information
16.4%
Earnings growth rate
21.3%
EPS growth rate
| Life Sciences earnings growth | 26.2% |
| Revenue growth rate | 10.1% |
| Future return on equity | 14.8% |
| Analyst coverage | Low |
| Last updated | 12 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 162 | 41 | 37 | 51 | 2 |
| 12/31/2025 | 152 | 36 | 28 | 32 | 3 |
| 12/31/2024 | 133 | 32 | 58 | 54 | 2 |
| 9/30/2024 | 131 | 28 | 22 | 28 | N/A |
| 6/30/2024 | 128 | 17 | 27 | 37 | N/A |
| 3/31/2024 | 128 | 31 | 27 | 39 | N/A |
| 12/31/2023 | 159 | 62 | 55 | 68 | N/A |
| 9/30/2023 | 158 | 54 | 40 | 53 | N/A |
| 6/30/2023 | 151 | 57 | 40 | 49 | N/A |
| 3/31/2023 | 142 | 42 | 42 | 47 | N/A |
| 12/31/2022 | 104 | 11 | -5 | -1 | N/A |
| 9/30/2022 | 119 | 41 | 40 | 43 | N/A |
| 6/30/2022 | 112 | 36 | 40 | 43 | N/A |
| 3/31/2022 | 111 | 36 | 37 | 41 | N/A |
| 12/31/2021 | 94 | 25 | 41 | 46 | N/A |
| 9/30/2021 | 71 | 11 | 3 | 6 | N/A |
| 6/30/2021 | 69 | 12 | 1 | 7 | N/A |
| 3/31/2021 | 65 | 9 | -12 | 9 | N/A |
| 12/31/2020 | 61 | 6 | -17 | 4 | N/A |
| 9/30/2020 | 54 | -3 | -16 | 7 | N/A |
| 6/30/2020 | 64 | 3 | -11 | 9 | N/A |
| 3/31/2020 | 60 | 6 | 4 | 9 | N/A |
| 12/31/2019 | 61 | 10 | 8 | 13 | N/A |
| 9/30/2019 | 58 | 12 | 7 | 10 | N/A |
| 6/30/2019 | 43 | 5 | 0 | 4 | N/A |
| 3/31/2019 | 40 | 1 | 2 | 3 | N/A |
| 12/31/2018 | 35 | -2 | -3 | -1 | N/A |
| 9/30/2018 | 31 | -4 | -4 | -2 | N/A |
| 6/30/2018 | 27 | -6 | N/A | -5 | N/A |
| 3/31/2018 | 24 | -7 | N/A | -9 | N/A |
| 12/31/2017 | 23 | -8 | N/A | -8 | N/A |
| 9/30/2017 | 21 | -9 | N/A | -9 | N/A |
| 6/30/2017 | 21 | -9 | N/A | -11 | N/A |
| 3/31/2017 | 20 | -14 | N/A | -15 | N/A |
| 12/31/2016 | 19 | -15 | N/A | -16 | N/A |
| 9/30/2016 | 17 | -16 | N/A | -18 | N/A |
| 6/30/2016 | 16 | -21 | N/A | -18 | N/A |
| 3/31/2016 | 14 | -18 | N/A | -14 | N/A |
| 12/31/2015 | 14 | -20 | N/A | -16 | N/A |
| 9/30/2015 | 13 | -25 | N/A | -18 | N/A |
| 6/30/2015 | 11 | -24 | N/A | -20 | N/A |
| 3/31/2015 | 10 | -23 | N/A | -21 | N/A |
| 12/31/2014 | 10 | -22 | N/A | -22 | N/A |
| 9/30/2014 | 8 | -20 | N/A | -18 | N/A |
| 6/30/2014 | 10 | -17 | N/A | -17 | N/A |
| 3/31/2014 | 11 | -16 | N/A | -14 | N/A |
| 12/31/2013 | 10 | -16 | N/A | -12 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 5GV's forecast earnings growth (16.4% per year) is above the savings rate (1%).
Earnings vs Market: 5GV's earnings (16.4% per year) are forecast to grow slower than the German market (21% per year).
High Growth Earnings: 5GV's earnings are forecast to grow, but not significantly.
Revenue vs Market: 5GV's revenue (10.1% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: 5GV's revenue (10.1% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 5GV's Return on Equity is forecast to be low in 3 years time (14.8%).